Skip to Content Facebook Feature Image

Next-Gen Omega-3 Solution: infinityseek Unveils Revolutionary Longevity Solution at BioST 2025 SG

Business

Next-Gen Omega-3 Solution: infinityseek Unveils Revolutionary Longevity Solution at BioST 2025 SG
Business

Business

Next-Gen Omega-3 Solution: infinityseek Unveils Revolutionary Longevity Solution at BioST 2025 SG

2025-12-17 14:47 Last Updated At:15:05

Highlighting advances in vascular aging research and microalgae-based Omega-3 innovation

SINGAPORE, Dec. 17, 2025 /PRNewswire/ -- The 5th World Biological Science and Technology Conference 2025 Singapore (BioST 2025 SG) opened in Singapore, bringing together leading researchers and industry experts from the global biotechnology sector.

The pioneer longevity brand infinityseek was invited to participate in the event, where it formally unveiled its groundbreaking anti-aging solution. The brand's research on vascular aging mechanisms drew strong interest from conference participants, while its flagship product attracted significant attention as a next-generation Omega-3 concept.

According to the Global Burden of Cardiovascular Diseases and Risk Factors Report, cardiovascular diseases (CVDs) remain the leading cause of death worldwide, with 437 million cases of associated disability recorded in 2023. Current interventions are primarily aimed at the middle to late stages of CVDs, while significant technological limitations remain in addressing the core pathological processes of systemic vascular aging. In response, infinityseek has focused on natural bio-resources, targeting both inflammation resolution and lipid metabolism, and has made a breakthrough with the rare microalgae Nannochloropsis.

During the presentation, infinityseek's scientific advisor highlighted the multiple advantages of this microalgae-derived formulation over conventional Omega-3 sourced from fish or krill. In particular, Nannochloropsis offers exceptional purity. Having originated 3.5 billion years ago and residing at the base of the marine food chain, it effectively avoids the accumulation of contaminants, ensuring the cleanliness and safety of its components from the source. The formulation also demonstrates significantly enhanced bioavailability, thanks to its natural polar lipid structure, which is highly compatible with the human body. Experimental data show that its bioavailability is 2.2 times higher than that of 97% EPA fish oil, with a 56% increase in key tissue accumulation[1].

Moreover, it operates through clear and targeted mechanisms of action, simultaneously addressing two critical pathways of vascular aging. Its abundant Ultra SPMs—third-generation specialized pro-resolving mediators—deliver potent anti-inflammatory effects within eight weeks,  substantially reducing the four major senescence-associated secretory phenotypes (SASPs)[2]. At the same time, its unique 100% Uni-EPA (free of DHA) precisely regulates lipid metabolism within four weeks[3], achieving targeted lipid-lowering effects. By concurrently modulating inflammation resolution and lipid metabolism, this solution is designed to slow vascular aging and support systemic, long-term health outcomes.

This breakthrough stems from infinityseek's ongoing commitment to rigorous scientific principles and a global evidence-based framework. The brand has established the Longevity Lab and collaborates closely with international institutions such as Germany's Lipidomix GmbH, building a comprehensive scientific system that spans from fundamental research to product validation. Its products have already received multiple authoritative certifications in China, the United States, and Germany.

"infinityseek's core philosophy lies in a profound respect for science and steadfast dedication to long-term, challenging scientific exploration and public education. Our goal is to enhance fundamental understanding of health and provide truly systemic and effective solutions," said the brand's R&D expert, Jains Pang.

With the formal publication of this research on top-tier international academic platforms, infinityseek not only demonstrates its research expertise in vascular aging interventions but also signals a new phase in the healthcare industry—one increasingly focused on mechanistic depth and the integration of global scientific knowledge. This development helps establish a new research pathway for addressing age-related health challenges on a global scale.

References:

[1] The data is derived from laboratory research at Hainan University. 

[2] The data is derived from laboratory research at Hainan University. 

[3] Meng, R., et al. (2025). Subcritical fluid and molecular distillation extraction of Nannochloropsis gaditana lipid and its metabolic benefits in hyperlipidemic mice. Frontiers in Nutrition, 12, 1615332. 

[1] The data is derived from laboratory research at Hainan University. 

[2] The data is derived from laboratory research at Hainan University. 

[3] Meng, R., et al. (2025). Subcritical fluid and molecular distillation extraction of Nannochloropsis gaditana lipid and its metabolic benefits in hyperlipidemic mice. Frontiers in Nutrition, 12, 1615332. 

 

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Next-Gen Omega-3 Solution: infinityseek Unveils Revolutionary Longevity Solution at BioST 2025 SG

Next-Gen Omega-3 Solution: infinityseek Unveils Revolutionary Longevity Solution at BioST 2025 SG

Next-Gen Omega-3 Solution: infinityseek Unveils Revolutionary Longevity Solution at BioST 2025 SG

Next-Gen Omega-3 Solution: infinityseek Unveils Revolutionary Longevity Solution at BioST 2025 SG

Next-Gen Omega-3 Solution: infinityseek Unveils Revolutionary Longevity Solution at BioST 2025 SG

Next-Gen Omega-3 Solution: infinityseek Unveils Revolutionary Longevity Solution at BioST 2025 SG

JAKARTA, Indonesia, Dec. 17, 2025 /PRNewswire/ -- Smart mobility technology Brand OMOWAY opened its 10-story Southeast Asia Regional Headquarters (RHQ) in Jakarta today. This milestone accelerates OMOWAY's global smart strategy in Southeast Asia. By integrating its OMO-X - the world's first mass-produced self-balancing smart electric motorcycle - with its advanced riding-assist technology, OMOWAY will usher the two-wheeler industry into a smart era of Motorcycle 3.0.

A Clear Vote of Confidence from Seasoned Local Dealers

At the opening, OMOWAY welcomed its first group of strategic partners, including dozens of dealers with decades of experience in the two-wheel sector. The partnership reflects growing market confidence in smart electric mobility and OMOWAY's product and local execution capabilities.

"After decades in the motorcycle industry, this is the most thrilling product I have encountered. It is truly epoch-making for the industry", commented an experienced dealer following the test ride.

OMOWAY's unique self-balancing system, combined with its own developed software and smart features, drives this disruption. It effectively improves the riding experience: no need to put feet down at low speeds, anti-slip cornering, self-parking and auto-grade encrypted digital keys. All features are built upon a highly integrated architecture with domain controllers and an in-house patented chassis.

"The commitment from experienced dealers confirms the smart electrification era has arrived," said OMOWAY co-founder Todd He. "We are delivering breakthrough innovation combined with a deep local understanding for our users. What we bring to the market is the next generation of smart mobility."

Full Core Market Coverage: Leading the Global Transition to Smart Mobility

The RHQ shows OMOWAY's transition from technological ambition to rapid on-the-ground expansion. Backed by strong channel-building capabilities, OMOWAY aims to bring smart electric motorcycles to every family across the country: By the first half of 2026, its sales & service network will fully cover the core markets of Java and Bali, expanding to Sumatra, Kalimantan and other major regions by year-end.

In parallel, OMOWAY is building a standardized after-sales system, a charging-service network and a talent programme that will train more than a thousand local professionals — creating a truly sustainable service ecosystem. Through the OMOWAY smart App, users will gain access to a transparent, efficient and reliable online-to-offline service experience.

Motorcycle 3.0: Smart E-Motorcycle Delivering Value to Families Worldwide

OMOWAY, with its full-stack in-house hardware and software development and core AI technologies, is emerging as a "definer" of two-wheel mobility. Its flagship model, OMO X — the world's first smart electric motorcycle equipped with a production-ready self-balancing riding-assist system — attracted widespread attention at its global brand launch in June.

The model tackles core challenges in low-speed traffic and congestion. It also brings a step-change in safety and significantly lower accident risk in uneven or wet conditions.

OMO X has recently passed certification by Indonesia's Ministry of Transportation, and OMOWAY's manufacturing lines are now preparing for mass production to support its 2026 market launch.

Drawing on deep expertise from the intelligent EV sector, OMOWAY is driven by technology and user-value to lower the barriers to high-tech adoption, delivering innovative smart product experiences to every life. With a global outlook, OMOWAY is steering the two-wheel industry into an intelligent new era — driving intelligence and sustainability globally.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

OMOWAY Unveils 10-Story RHQ, Accelerating Two-Wheeler's Smart 3.0 Shift

OMOWAY Unveils 10-Story RHQ, Accelerating Two-Wheeler's Smart 3.0 Shift

Recommended Articles